Geode Capital Management
ZVSA

Geode Capital Management’s ZyVersa Therapeutics ZVSA Stock Holding History

Geode Capital Management’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,706
Closed -$14.7K – 4579
2025
Q2 		$14.7K Hold
21,706
– – ﹤0.01% 4397
2025
Q1 		$13.6K Buy
+21,706
New +$24.5K ﹤0.01% 4409
2023
Q4 		– Sell
-352
Closed -$16.1K – 4690
2023
Q3 		$16.1K Buy
+352
New +$20.9K ﹤0.01% 4665

Other funds holding ZVSA

GA
Guerra Advisors Miami, Florida $271M AUM 27.78% 1-Year Est. Return

Geode Capital Management's ZVSA Position: Q3 2025 in Review

Geode Capital Management sold out of ZyVersa Therapeutics (ZVSA) in Q3 2025, closing a stake of 21,706 shares — an estimated $14.7K sold.

Geode Capital Management first reported a position in ZVSA in Q3 2023 and held it in 3 quarters. The position peaked at $16.1K in Q3 2023. 1 fund tracked by Wall St. Rank holds ZVSA as of Q3 2025.

  • Geode Capital Management reported no remaining ZyVersa Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Geode Capital Management sold 21,706 ZyVersa Therapeutics shares in Q3 2025, an estimated $14.7K.
  • Geode Capital Management first reported a position in ZyVersa Therapeutics in Q3 2023 and held it in 3 quarters.
  • Geode Capital Management's ZyVersa Therapeutics position peaked at $16.1K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics as of Q3 2025.

Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.